HydroMARK™
Breast Biopsy Site Marker
Exclusive hydrogel technology provides clinicians with long-term ultrasound visibility.1, 2
HydroMARK™ Breast Biopsy Site Marker
Highly Visible
The HydroMARK™ markers hydrate to provide long-term visibility even after neoadjuvant chemotherapy.2
Allows Easier Localization
Consistently place any localization device under ultrasound.3
Creates a Better Patient Experience
Localization under ultrasound provides a faster, more comfortable procedure for the patient.4
Conspicuity Under MRI
The HydroMARK™ markers are uniquely distinguishable during a T2 sequence.5
Three distinct shapes for visibility
- Open Coil
- Butterfly
- Barrel
“We use the HydroMARK™ marker exclusively for all of our biopsies. We have had such a great experience with the HydroMARK™ marker that we need no other clip.”
Robin B. Shermis, MD, MPH, FACR
Medical Director, ProMedica Breast Care on the campus of The Toledo Hospital
Frequently Asked Questions
What is the composition of the hydrogel?
The hydrogel is composed of polyethylene glycol (PEG).
Does the HydroMARK™ marker contain nickel?
The HydroMARK™ titanium products contain no nickel.
What is the duration of the HydroMARK™ marker´s enhanced long-term visibility?
Studies have shown that visibility can last up to 12 months in some patients.1
Related Products
MammoSTAR® Biopsy Site Marker
The all-natural biopsy marker provides a non-metal marking alternative with a long-lasting beta glucan carrier for unique patient sensitivities.
MammoMARK® & CorMARK® Biopsy Site Identifier
Rapid collagen expansion anchors the marker within the biopsy cavity reducing the likelihood of movement. 6, 7
1. Sakamoto, N., Fukuma, E., Tsunoda, Y. et al. Evaluation of the dislocation and long-term sonographic detectability of a hydrogel based breast biopsy site marker. Breast Cancer 25, 575–582 (2018). https://doi.org/10.1007/s12282-018-0854-8
2. Pinkney, Journal of Diagnostic Medical Sonography 29(4) 151 – 158, DOI 10.1177/8756479313486962
3. Blumencranz, Ann. Surg. Oncol. (2014) 21:3273-3277, DOI 10.1245/s10434-014-3917-x)
4. Gentile, Ann Surg Oncol. 2016 Oct;23(10):3284-9. doi: 10.1245/s10434-016-5325-x. Epub 2016 Jun 23.
5. Shah, Clin Imaging. 2019 May – Jun;55:196-212. doi: 10.1016/j.clinimag.2019.05.014. Epub 2019 Jun 14.
6. MammoMARKRK® Device Test- PRC043442 Rev B, pgs. 2, 5-6: Collagen Expansion
7. Corsi, F., Sorrentino, L., Sartani, A., Bossi, D., Amadori, R., Nebuloni, M., Truffi, M., Bonzini, M., & Foschi, D. (2015). Localization of nonpalpable breast lesions with sonographically visible clip: Optimizing tailored resection and clear margins. The American Journal of Surgery, 209(6), 950-958
Products may not be approved or available in your region. Please check with your local Mammotome representative.